Vorapaxar in the long-term secondary prevention of atherothrombotic events: a profile of its use in the USA
Crossref DOI link: https://doi.org/10.1007/s40267-017-0407-9
Published Online: 2017-05-06
Published Print: 2017-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
McKeage, Kate
Lyseng-Williamson, Katherine A. http://orcid.org/0000-0002-5104-1158
Frampton, James E.
License valid from 2017-05-06